Showing results (181-190 of 229) with videos related to
Sort By:
Pageof 23
Nature Genetics|June 3, 2020
Unraveling tumor-immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapyAlejandro Jiménez-Sánchez, Paulina Cybulska, Katherine LaVigne Mager, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 11, 2022
Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and OutcomesKelly L Bolton, Denise Chen, Rosario Corona de la Fuente, et al.Nature Genetics|August 15, 2018
Copy number signatures and mutational processes in ovarian carcinomaGeoff Macintyre, Teodora E Goranova, Dilrini De Silva, et al.Science Translational Medicine|November 9, 2018
Enhanced detection of circulating tumor DNA by fragment size analysisFlorent Mouliere, Dineika Chandrananda, Anna M Piskorz, et al.Nature Communications|February 18, 2017
CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumoursHong Xu, Marco Di Antonio, Steven McKinney, et al.The New England Journal of Medicine|June 12, 2009
Mutation of FOXL2 in granulosa-cell tumors of the ovarySohrab P Shah, Martin Köbel, Janine Senz, et al.Nature Reviews. Cancer|April 13, 2026
Rethinking ovarian cancer III: the past decade and future directionsFrances R Balkwill, Céline M Laumont, Nikki Burdett, et al.Nature Reviews. Cancer|October 24, 2015
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancerDavid D Bowtell, Steffen Böhm, Ahmed A Ahmed, et al.Nature Genetics|December 1, 2022
The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancerDale W Garsed, Ahwan Pandey, Sian Fereday, et al.Oncotarget|September 9, 2017
Germline whole exome sequencing and large-scale replication identifies <i>FANCM</i> as a likely high grade serous ovarian cancer susceptibility geneEd Dicks, Honglin Song, Susan J Ramus, et al.Pageof 23